Stay updated on Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial page.

Latest updates to the Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial page
- Check4 days agoChange DetectedA site-wide banner announces an NIH transition notice stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.2.SummaryDifference0.2%

- Check24 days agoChange DetectedThe 403 Forbidden message and its Home button are gone, but the clinical trial record area is blank.SummaryDifference0.5%

- Check31 days agoChange DetectedAccess to the study's Researcher view now returns a 403 Forbidden page, instead of displaying the trial details. This indicates an access/permissions issue that prevents viewing the core content and related navigation on the study record page.SummaryDifference17%

- Check38 days agoChange DetectedThe page software version was updated from v3.6.6 to v3.7.0, indicating a platform update. It does not change the displayed study data or core content of the Researcher View page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page footer now displays Revision: v3.6.6, replacing v3.6.5. This indicates a small maintenance update to the page without altering the study information or how users interact with it.SummaryDifference0.1%

Stay in the know with updates to Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity and Safety of NBP606 in Healthy Infants Clinical Trial page.